Cargando…
Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?
High-dose chemotherapy has long been advocated as a means of controlling drug resistance in infectious diseases but recent empirical studies have begun to challenge this view. We develop a very general framework for modeling and understanding resistance emergence based on principles from evolutionar...
Autores principales: | Day, Troy, Read, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731197/ https://www.ncbi.nlm.nih.gov/pubmed/26820986 http://dx.doi.org/10.1371/journal.pcbi.1004689 |
Ejemplares similares
-
Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens
por: Huijben, Silvie, et al.
Publicado: (2013) -
The economics of managing evolution
por: Day, Troy, et al.
Publicado: (2021) -
A stochastic analysis of the interplay between antibiotic dose, mode of action, and bacterial competition in the evolution of antibiotic resistance
por: Czuppon, Peter, et al.
Publicado: (2023) -
Pathogen evolution during vaccination campaigns
por: Day, Troy, et al.
Publicado: (2022) -
Resource limitation prevents the emergence of drug resistance by intensifying within-host competition
por: Wale, Nina, et al.
Publicado: (2017)